Literature DB >> 29890221

Misfolded rhodopsin mutants display variable aggregation properties.

Megan Gragg1, Paul S-H Park2.   

Abstract

The largest class of rhodopsin mutations causing autosomal dominant retinitis pigmentosa (adRP) is mutations that lead to misfolding and aggregation of the receptor. The misfolding mutants have been characterized biochemically, and categorized as either partial or complete misfolding mutants. This classification is incomplete and does not provide sufficient information to fully understand the disease pathogenesis and evaluate therapeutic strategies. A Förster resonance energy transfer (FRET) method was utilized to directly assess the aggregation properties of misfolding rhodopsin mutants within the cell. Partial (P23H and P267L) and complete (G188R, H211P, and P267R) misfolding mutants were characterized to reveal variability in aggregation properties. The complete misfolding mutants all behaved similarly, forming aggregates when expressed alone, minimally interacting with the wild-type receptor when coexpressed, and were unresponsive to treatment with the pharmacological chaperone 9-cis retinal. In contrast, variability was observed between the partial misfolding mutants. In the opsin form, the P23H mutant behaved similarly as the complete misfolding mutants. In contrast, the opsin form of the P267L mutant existed as both aggregates and oligomers when expressed alone and formed mostly oligomers with the wild-type receptor when coexpressed. The partial misfolding mutants both reacted similarly to the pharmacological chaperone 9-cis retinal, displaying improved folding and oligomerization when expressed alone but aggregating with wild-type receptor when coexpressed. The observed differences in aggregation properties and effect of 9-cis retinal predict different outcomes in disease pathophysiology and suggest that retinoid-based chaperones will be ineffective or even detrimental.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor; Phototransduction; Protein aggregation; Protein misfolding; Retinal degeneration; Retinitis pigmentosa

Mesh:

Substances:

Year:  2018        PMID: 29890221      PMCID: PMC6066411          DOI: 10.1016/j.bbadis.2018.06.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  54 in total

1.  Misfolded opsin mutants display elevated β-sheet structure.

Authors:  Lisa M Miller; Megan Gragg; Tae Gyun Kim; Paul S-H Park
Journal:  FEBS Lett       Date:  2015-09-07       Impact factor: 4.124

2.  Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled.

Authors:  J Hwa; P Garriga; X Liu; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa.

Authors:  Rahul S Rajan; Ron R Kopito
Journal:  J Biol Chem       Date:  2004-10-27       Impact factor: 5.157

4.  Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes.

Authors:  Yan Liang; Dimitrios Fotiadis; Sławomir Filipek; David A Saperstein; Krzysztof Palczewski; Andreas Engel
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

5.  Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain.

Authors:  C H Sung; C M Davenport; J Nathans
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

6.  Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa.

Authors:  Hugo F Mendes; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2008-07-17       Impact factor: 6.150

7.  Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

Authors:  Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario R Romano; Andrea Binotto; Ciro Costagliola
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

8.  Improved methodical approach for quantitative BRET analysis of G Protein Coupled Receptor dimerization.

Authors:  Bence Szalai; Péter Hoffmann; Susanne Prokop; László Erdélyi; Péter Várnai; László Hunyady
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

9.  Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration.

Authors:  Dimitra Athanasiou; Monica Aguila; Chikwado A Opefi; Kieron South; James Bellingham; Dalila Bevilacqua; Peter M Munro; Naheed Kanuga; Francesca E Mackenzie; Adam M Dubis; Anastasios Georgiadis; Anna B Graca; Rachael A Pearson; Robin R Ali; Sanae Sakami; Krzysztof Palczewski; Michael Y Sherman; Philip J Reeves; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

10.  The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation.

Authors:  Richard S Saliba; Peter M G Munro; Philip J Luthert; Michael E Cheetham
Journal:  J Cell Sci       Date:  2002-07-15       Impact factor: 5.285

View more
  12 in total

1.  Flavonoids enhance rod opsin stability, folding, and self-association by directly binding to ligand-free opsin and modulating its conformation.

Authors:  Joseph T Ortega; Tanu Parmar; Beata Jastrzebska
Journal:  J Biol Chem       Date:  2019-04-03       Impact factor: 5.157

Review 2.  Rhodopsin Oligomerization and Aggregation.

Authors:  Paul S-H Park
Journal:  J Membr Biol       Date:  2019-07-08       Impact factor: 1.843

3.  Detection of misfolded rhodopsin aggregates in cells by Förster resonance energy transfer.

Authors:  Megan Gragg; Paul S-H Park
Journal:  Methods Cell Biol       Date:  2018-09-17       Impact factor: 1.441

4.  Retinal degeneration in mice expressing the constitutively active G90D rhodopsin mutant.

Authors:  Alejandro T Colozo; Sreelakshmi Vasudevan; Paul S-H Park
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

5.  Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.

Authors:  Alicia Arranz-Romera; Sergio Esteban-Pérez; Irene T Molina-Martínez; Irene Bravo-Osuna; Rocío Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2021-02-27       Impact factor: 4.617

6.  Differential Aggregation Properties of Mutant Human and Bovine Rhodopsin.

Authors:  Sreelakshmi Vasudevan; Paul S-H Park
Journal:  Biochemistry       Date:  2020-12-27       Impact factor: 3.162

Review 7.  Supramolecular organization of rhodopsin in rod photoreceptor cell membranes.

Authors:  Paul S-H Park
Journal:  Pflugers Arch       Date:  2021-02-16       Impact factor: 4.458

Review 8.  Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Eduardo Jardón-Valadez
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 9.  Structural aspects of rod opsin and their implication in genetic diseases.

Authors:  Francesca Fanelli; Angelo Felline; Valeria Marigo
Journal:  Pflugers Arch       Date:  2021-03-16       Impact factor: 3.657

Review 10.  The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor.

Authors:  Joseph T Ortega; Beata Jastrzebska
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.